All In Biotech

Drug Trial Radar · NCT07700238

A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Newly Diagnosed Previously Untreated Primary Immune Thrombocytopenia (ITP)

A Phase 3, Randomized, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Adults With Newly Diagnosed Previously Untreated Primary Immune Thrombocytopenia (ITP).

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 126 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

126

Planned (sponsor's estimate)

Start

Oct 15, 2026

Primary completion

Sep 14, 2029

Study completion Oct 14, 2029

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Jul 13, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 3 study is designed to evaluate the efficacy and safety of romiplostim in combination with predniso(lo)ne compared with predniso(lo)ne alone in adults with previously newly diagnosed untreated Primary Immune Thrombocytopenia (ITP).

Conditions

  • Primary Immune Thrombocytopenia

Interventions

  • RomiplostimDrug

    Administered subcutaneously.

  • Predniso(lo)neDrug

    Administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With a Durable Platelet Response (DPR)Time frame: 8 weeks

Locations

21 sites in 5 countries. Site status is shown where the registry gives one.

  • MemorialCare Long Beach Medical Center

    Long Beach, California · Recruiting

  • The Bleeding and Clotting Disorders Institute

    Peoria, Illinois · Recruiting

  • Duke University Medical Center

    Durham, North Carolina · Recruiting

  • Hematology Oncology Associates of Fredericksburg

    Fredericksburg, Virginia · Recruiting

  • Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin

    Berlin, Germany · Recruiting

  • Universitaetsklinikum Dresden

    Dresden, Germany · Recruiting

  • Klinikum der Justus-Liebig-Universitaet

    Giessen, Germany · Recruiting

  • Universitaetsklinikum Jena

    Jena, Germany · Recruiting

  • Semmelweis Egyetem

    Budapest, Hungary · Recruiting

  • Debreceni Egyetem Klinikai Kozpont

    Debrecen, Hungary · Recruiting

  • Heves Varmegyei Markhot Ferenc Oktatokorhaz es Rendelointezet

    Eger, Hungary · Recruiting

  • Pecsi Tudomanyegyetem Klinikai Kozpont

    Kaposvár, Hungary · Recruiting

  • Hospital General Universitario Gregorio Maranon

    Madrid, Spain · Recruiting

  • Hospital General Universitario Morales Meseguer

    Murcia, Spain · Recruiting

  • Hospital Universitario Virgen del Rocio

    Seville, Andalusia, Spain · Recruiting

  • Hospital Universitari Vall d Hebron

    Barcelona, Catalonia, Spain · Recruiting

  • Adnan Menderes Universitesi Tip Fakultesi

    Aydin, Turkey (Türkiye) · Recruiting

  • Trakya Universitesi Tip Fakultesi

    Edirne, Turkey (Türkiye) · Recruiting

  • Istanbul Universitesi Cerrahpasa Tip Fakultesi

    Istanbul, Turkey (Türkiye) · Recruiting

  • Bagcilar Medipol Mega Universite Hastanesi

    Istanbul, Turkey (Türkiye) · Recruiting

  • Kocaeli Universitesi Tip Fakultesi Hastanesi

    Kocaeli, Turkey (Türkiye) · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.